Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis

Journal of Clinical Oncology(2024)10.1200/jco.24.00332Source: DataRank Database

Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis is a research paper published in Journal of Clinical Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.13)OA: greenTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Ahmed Ansari ORCID,Sameer A. Parikh ORCID,Sara J. Achenbach,Kari G. Rabe ORCID,Aaron D. Norman ORCID

Live enrichment

PubMed:39231386 PMC:PMC11624097 OpenAlex:https://openalex.org/W4402217423

NIA NIH HHS

Grant: R33 AG058738

NIA NIH HHS

Grant: R21 AG058738

NIA NIH HHS

Grant: R01 AG058266

NCI NIH HHS

Grant: P30 CA015083

FWCI

1.13

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11624097/pdf/nihms-2005045.pdf

publisherhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO.24.00332

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11624097/

journalhttps://doi.org/10.1200/jco.24.00332

Fields of Study

Chronic Lymphocytic Leukemia ResearchMultiple Myeloma Research and TreatmentsCutaneous lymphoproliferative disorders researchHumansMaleMelanomaFemaleLymphocytosisMiddle AgedAgedIncidenceAdultB-LymphocytesRisk FactorsSkin NeoplasmsLeukemia, Lymphocytic, Chronic, B-CellAged, 80 and over

MeSH Terms

AdultAgedAged, 80 and overB-LymphocytesFemaleHumansLymphocytosisMaleMelanomaMiddle AgedRisk FactorsSkin NeoplasmsLeukemia, Lymphocytic, Chronic, B-CellIncidence

Keywords

MedicineLymphocytosisCumulative incidenceChronic lymphocytic leukemiaHazard ratioMelanomaInternal medicineProportional hazards modelIncidence (geometry)CD5ImmunologyLeukemiaOncologyCohortConfidence intervalLymphomaCancer research

Sustainable Development Goals

SDG 0: Good health and well-being